The idea that a swallowing problem could be hormonal genuinely blindsided me when I first came across the research. So many women describe the exact same thing — food sticking, quiet panic at restaurants, being told it's anxiety or acid reflux — and never once being asked where they are in their hormonal journey. If this is happening to you in midlife, you are not imagining it, and you are definitely not alone.
Learn more about Rose →Estrogen receptors (ERα and ERβ) are expressed throughout the esophageal mucosa, where they help calibrate local immune responses and suppress unnecessary inflammation. When estrogen levels fall sharply during perimenopause, this regulatory brake is partially released, leaving the esophageal lining more vulnerable to immune overactivation — including the eosinophil recruitment that defines EoE. This is not a theoretical pathway; estrogen's role as an immune modulator in mucosal tissue is well established across multiple organ systems.
Eosinophils are white blood cells that, in EoE, infiltrate the esophageal lining and cause the thickening, ringing, and narrowing that makes swallowing painful or impossible. Research in allergic and inflammatory conditions shows that estrogen suppresses eosinophil survival and migration in mucosal tissues, meaning that lower estrogen can translate to unchecked eosinophil activity. This mechanism helps explain why some women develop EoE symptoms for the first time in their late forties or fifties with no prior history of food allergy.
The gastrointestinal immune system undergoes measurable changes during menopause, including shifts in mucosal permeability and local cytokine signalling — the chemical messengers that direct immune cells where to go. Estrogen helps maintain tight junction integrity in gastrointestinal mucosa, and its decline is associated with increased barrier permeability sometimes called 'leaky gut,' which can amplify systemic and local inflammatory responses. When this occurs at the esophageal level, dietary antigens that were previously tolerated may begin triggering an eosinophilic response.
Mast cells, which sit alongside eosinophils in the inflammatory cascade seen in EoE, are themselves regulated by sex hormones — estrogen generally inhibits mast cell degranulation while progesterone can enhance it. As both hormones fluctuate chaotically in perimenopause and then estrogen declines in postmenopause, mast cell behaviour becomes less predictable, potentially amplifying allergic and inflammatory signalling in the esophagus. Several researchers studying the sex-based differences in EoE prevalence have pointed to this mast cell–hormone axis as a likely contributor.
Many perimenopausal women report developing sensitivities to foods they previously ate without issue — wheat, dairy, eggs, and tree nuts are among the most common EoE dietary triggers — and are typically told this is irritable bowel syndrome or general digestive slowing. In EoE, these sensitivities are driven by an esophageal immune response rather than a gastrointestinal one, which is why the symptom is dysphagia (difficulty swallowing) rather than bloating or diarrhoea. The hormonal context of when these sensitivities emerge deserves far more clinical attention than it currently receives.
EoE and gastroesophageal reflux disease (GERD) share overlapping symptoms — heartburn, chest discomfort, and a sensation of food sitting in the chest — which means EoE is frequently misdiagnosed as GERD and treated with proton pump inhibitors that do little to address the underlying immune process. Menopausal women are already at higher risk of GERD due to reduced lower esophageal sphincter tone associated with estrogen loss, making it even easier for clinicians to anchor on that diagnosis and miss EoE entirely. A definitive EoE diagnosis requires endoscopy with biopsy, not a trial of antacids.
Emerging data suggest that menopausal hormone therapy (MHT) may dampen the kind of mucosal immune dysregulation that underpins EoE, consistent with estrogen's broader anti-inflammatory role in epithelial tissues. While no large RCTs have yet directly tested MHT as a treatment for EoE, observational data and the mechanistic evidence for estrogen's role in esophageal immune regulation make this a credible and under-researched hypothesis. Women who develop swallowing problems around menopause and are considering MHT for other reasons may find it worth raising this specific question with their specialist.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.